Tasocitinib (CP 690550) supplier|cas 477600-75-2 |DC Chemicals|Supplier|Price|Buy

DC Chemicals Supply: Tasocitinib (CP 690550) supplier,cas 477600-75-2, Cat No. DC5165, In stock

Contact: website: www.dcchemicals.com,

sales@dcchemicals.com,order@dcchemicals.com,info@dcchemicals.com,
Tel: +86-21-61454686;Fax:+86-21-61642880；

Product name: Tofacitinib (CP-690550) Citrate, Synonym:　CP-690550; Tofacitinib; tasocitinib, Cat No. DC5165, Cas: 540737-29-9, Chemical Name:3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile, Molecular Formula: C16H20N6O, MW: 312.37

Tasocitinib (CP 690550),cas 477600-75-2, Purity: >98%. Best Price and quality in the market,DC Chemicals,Primary Manufacturer, confirmed by HNMR and HPLC. Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent versus JAK2 and JAK1. Phase 3.

Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection.